Literature DB >> 12028036

Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting system.

Claudia Voena1, Giovanni Locatelli, Claudia Castellino, Paola Omedè, Marco Ladetto, Elisabetta Zappone, Raffaella Milani, Vittorio Perfetti, Mario Boccadoro, Alessandro Pileri, Paolo Lusso, Chiara Villa, Mauro Malnati, Paolo Corradini.   

Abstract

The purging efficacy of the Miltenyi sorting system was evaluated by qualitative and TaqMan quantitative polymerase chain reaction (PCR) in myeloma patients, using immunoglobulin genes. After small-scale selection, qualitative PCR showed that in 6 of 12 leukaphereses myeloma cells were no longer detectable. Envisaging a possible clinical application, the leukaphereses from three patients underwent large-scale selection. Qualitative PCR showed that myeloma cells were still detectable. Quantitative PCR, performed in two patients, showed a tumour depletion of 1 and 2 logs respectively. Although numbers are small, the promising results obtained with small-scale selection were not reproduced in large-scale experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028036     DOI: 10.1046/j.1365-2141.2002.03448.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virus.

Authors:  Eric Bartee; Winnie M Chan; Jan S Moreb; Christopher R Cogle; Grant McFadden
Journal:  Biol Blood Marrow Transplant       Date:  2012-04-16       Impact factor: 5.742

2.  Reovirus as a successful ex vivo purging modality for multiple myeloma.

Authors:  C M Thirukkumaran; Z Q Shi; J Luider; K Kopciuk; N Bahlis; P Neri; M Pho; D Stewart; A Mansoor; D G Morris
Journal:  Bone Marrow Transplant       Date:  2013-08-26       Impact factor: 5.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.